Element Biosciences, Inc.
San Diego, CA
- UEI
- CZ2CHES131A5
- CAGE
- 8HYT1
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 10055 Barnes Canyon Rd Suite 100, San Diego, CA 92121, USA
- Website
- elementbiosciences.com
- Founded
- 2017
- Employees
- 251-1K
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $721,576 |
| FY2025 | $781,357 |
| FY2024 | $508,777 |
| FY2023 | $614,564 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Agriculture | $381,486 | |
| 2 | Department of Health and Human Services | $340,090 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Illumina, Inc. | San Diego, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Bionano Genomics, Inc. | San Diego, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Pacific Biosciences Of California, Inc. | Menlo Park, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Oxford Nanopore Technologies, Inc. | New York, NY | 334516 Analytical Laboratory Instrument Manufacturing |
| Chapter Diagnostics Inc. | Menlo Park, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Element Biosciences, Inc., a San Diego-based small disadvantaged business, manufactures next-generation DNA sequencing platforms and consumables, selling the AVITI and AVITI24 benchtop whole-genome sequencing systems and associated sequencing kits directly to federal research agencies as a prime contractor across civilian life-sciences and agricultural missions. The company operates exclusively as a prime (100% of recent awards) with no subcontract footprint and no parent vehicle participation except task orders under a single-award internal-delivery contract it holds with USDA.
Element's customer base concentrates on the Department of Agriculture, which accounts for 99% of combined potential value. USDA's Agricultural Research Service (ARS) divisions dominate the award portfolio: the Central Program Planning Coordination and Support function placed the largest single vehicle — an $8 million five-year indefinite-delivery contract awarded August 1, 2026, with a July 31, 2031 completion date covering instrumentation, supplies, and support across the Aviti, Aviti24, and Vitari platform families under a sole-source, restricted procurement citing Element's exclusive Avidite Base Chemistry sequencing-by-binding technology. The Pacific West Area and Plains Area field research offices together account for nine purchase orders and delivery orders valued at approximately $2 million for AVITI systems (ranging from $135 thousand to $373 thousand per unit) and consumable sequencing kits destined for Hawaiian and Texas research facilities. The Centers for Disease Control and Prevention placed three awards totaling $667 thousand for AVITI systems and lab equipment services (2023–2024). The National Institutes of Health National Cancer Institute procured one $315 thousand AVITI24 system in September 2026 under FAR 12.201-1 sole-source for the Center for Cancer Research at the NCI Main Campus in Bethesda, Maryland. Recent awards are not set-aside-designated; the two USDA ARS purchase orders from 2025–2026 that explicitly identified set-aside status were Total Small Business set-asides.
Activity has accelerated from two awards in 2022 to five in 2026, with a combined potential value of $11.1 million. Three awards (combined potential value $598 thousand) face ultimate completion inside the next twenty-four months, representing modest recompete exposure. Obligated dollars total $3 million, or 27% of combined potential, reflecting the long performance windows typical of equipment procurement and service-plan contracts. Awards are classified predominantly under NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and PSC 6640 (Laboratory Equipment and Supplies), with recent contracts specifying firm fixed-price terms and delivery either to San Diego for manufacturing or to customer sites in Hawaii, Texas, Maryland, and Georgia. The August 2026 indefinite-delivery contract represents the vendor's anchor relationship with federal research infrastructure, securing sole-source renewal rights through 2031 across multiple USDA ARS locations already operating Element sequencing platforms.
Quick answers
Is Element Biosciences, Inc. registered in SAM.gov?
Yes. Element Biosciences, Inc.'s SAM.gov registration is active through August 27, 2027.
What is Element Biosciences, Inc.'s CAGE code?
Element Biosciences, Inc.'s CAGE code is 8HYT1, and its Unique Entity ID (UEI) is CZ2CHES131A5.
How much has Element Biosciences, Inc. received in federal contracts?
Federal contracts obligated $781,357 to Element Biosciences, Inc. in fiscal year 2025 and $2,626,274 in fiscal years 2023 through 2027.
What is Element Biosciences, Inc.'s most recent federal award?
Element Biosciences, Inc.'s most recent federal contract award is The purpose of this acquisition is to enhance the shared research capabilities of the national cancer institute… (140D0426P0333), from Interior Business Center (DO), on September 23, 2026.
On GovTribe
See Element Biosciences, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors